Capital Fund Management S.A. Sells 11,993 Shares of Dolby Laboratories $DLB

Capital Fund Management S.A. trimmed its stake in shares of Dolby Laboratories (NYSE:DLB) by 33.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,403 shares of the electronics maker’s stock after selling 11,993 shares during the quarter. Capital Fund Management S.A.’s holdings in Dolby Laboratories were worth $1,812,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in DLB. Vanguard Group Inc. grew its stake in shares of Dolby Laboratories by 7.1% during the first quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock worth $605,194,000 after buying an additional 502,110 shares during the last quarter. Geode Capital Management LLC grew its position in Dolby Laboratories by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 1,556,571 shares of the electronics maker’s stock worth $116,159,000 after acquiring an additional 30,057 shares during the last quarter. Acadian Asset Management LLC grew its position in Dolby Laboratories by 1.7% during the 2nd quarter. Acadian Asset Management LLC now owns 1,160,661 shares of the electronics maker’s stock worth $86,172,000 after acquiring an additional 19,840 shares during the last quarter. AQR Capital Management LLC increased its holdings in Dolby Laboratories by 63.6% in the 1st quarter. AQR Capital Management LLC now owns 1,143,978 shares of the electronics maker’s stock worth $90,946,000 after purchasing an additional 444,718 shares in the last quarter. Finally, Boston Trust Walden Corp raised its position in Dolby Laboratories by 2.1% in the second quarter. Boston Trust Walden Corp now owns 1,098,218 shares of the electronics maker’s stock valued at $81,554,000 after purchasing an additional 22,404 shares during the last quarter. Institutional investors own 58.56% of the company’s stock.

Insider Buying and Selling

In other Dolby Laboratories news, SVP John D. Couling sold 6,164 shares of Dolby Laboratories stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $66.12, for a total transaction of $407,563.68. Following the transaction, the senior vice president directly owned 115,338 shares of the company’s stock, valued at $7,626,148.56. The trade was a 5.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $65.55, for a total transaction of $196,650.00. Following the completion of the sale, the senior vice president owned 67,435 shares of the company’s stock, valued at approximately $4,420,364.25. This represents a 4.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 100,363 shares of company stock valued at $6,877,014 in the last 90 days. Insiders own 38.39% of the company’s stock.

Dolby Laboratories Stock Down 0.0%

DLB stock opened at $66.29 on Thursday. The company’s fifty day simple moving average is $67.80 and its 200 day simple moving average is $71.82. Dolby Laboratories has a 12-month low of $64.02 and a 12-month high of $89.66. The firm has a market cap of $6.33 billion, a price-to-earnings ratio of 25.20 and a beta of 0.89.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. The company had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The firm’s revenue was up .7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd will be given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, December 2nd. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s payout ratio is currently 54.75%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Robert W. Baird assumed coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 price target on the stock. Barrington Research cut their target price on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday. Rosenblatt Securities dropped their price target on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Finally, Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Dolby Laboratories has an average rating of “Moderate Buy” and an average target price of $92.00.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.